US Stock MarketDetailed Quotes

ORGO Organogenesis

Watchlist

2.850
+0.030+1.06%

Close Oct 2 16:00 ET

2.850
0.0000.00%

Post 20:01 ET

377.84MMarket Cap-23750P/E (TTM)

Organogenesis Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

11.01%130.23M

2.17%109.98M

-3.94%433.14M

-13.73%99.65M

-7.13%108.53M

-3.36%117.32M

10.84%107.64M

-3.52%450.89M

-9.65%115.52M

2.73%116.86M

Operating revenue

11.01%130.23M

2.17%109.98M

-3.94%433.14M

-13.73%99.65M

-7.13%108.53M

-3.36%117.32M

10.84%107.64M

-3.52%450.89M

-9.65%115.52M

2.73%116.86M

Cost of revenue

10.95%29.2M

7.85%28.7M

1.39%106.48M

2.43%27.77M

-1.48%25.79M

-1.26%26.32M

6.09%26.61M

-8.04%105.02M

-16.83%27.11M

0.04%26.18M

Gross profit

11.03%101.04M

0.30%81.28M

-5.56%326.66M

-18.69%71.88M

-8.76%82.74M

-3.96%91M

12.49%81.04M

-2.06%345.87M

-7.20%88.41M

3.53%90.68M

Operating expense

13.38%92.13M

0.11%85.13M

-2.92%314.13M

-8.20%73.15M

-15.98%74.69M

-1.88%81.26M

17.84%85.04M

15.17%323.57M

5.53%79.69M

24.65%88.9M

Selling and administrative expenses

8.85%76.54M

-2.05%72.32M

-4.95%269.75M

-10.12%61.38M

-19.04%64.22M

-3.16%70.32M

16.13%73.83M

13.43%283.81M

1.55%68.29M

27.19%79.33M

Research and development costs

42.50%15.59M

14.35%12.81M

11.61%44.38M

3.29%11.77M

9.35%10.47M

7.18%10.94M

30.45%11.2M

29.34%39.76M

37.95%11.4M

6.95%9.58M

Operating profit

-8.58%8.91M

3.72%-3.85M

-43.84%12.53M

-114.56%-1.27M

352.50%8.05M

-18.35%9.75M

-3,025.78%-4M

-69.12%22.3M

-55.86%8.72M

-89.06%1.78M

Net non-operating interest income expense

-4.38%-620K

20.80%-514K

-9.01%-2.19M

-1,773.33%-502K

22.38%-444K

18.63%-594K

11.94%-649K

72.24%-2.01M

103.52%30K

61.40%-572K

Non-operating interest expense

4.38%620K

-20.80%514K

9.01%2.19M

1,773.33%502K

-22.38%444K

-18.63%594K

-11.94%649K

-72.24%2.01M

-103.52%-30K

-61.40%572K

Other net income (expense)

-81,632.14%-22.83M

0.00%23K

538.46%57K

-516.67%-25K

520.00%31K

233.33%28K

866.67%23K

99.31%-13K

166.67%6K

100.26%5K

Special income (charges)

---22.8M

----

--0

----

--0

----

--0

----

-Less:Impairment of capital assets

--18.84M

----

--0

----

-Write off

--3.96M

----

--0

----

Other non- operating income (expenses)

-200.00%-28K

0.00%23K

538.46%57K

-516.67%-25K

520.00%31K

233.33%28K

866.67%23K

0.00%-13K

166.67%6K

126.32%5K

Income before tax

-258.41%-14.54M

6.14%-4.34M

-48.76%10.39M

-120.52%-1.8M

530.12%7.64M

-17.93%9.18M

-433.06%-4.63M

-67.85%20.28M

-53.66%8.75M

-90.59%1.21M

Income tax

-35.21%2.5M

-35.28%-2.24M

14.67%5.45M

-196.85%-1.23M

348.35%4.47M

58.32%3.86M

-3,784.44%-1.66M

115.27%4.75M

103.95%1.27M

229.04%997K

Net income

-420.60%-17.04M

29.27%-2.1M

-68.16%4.95M

-107.59%-568K

1,373.02%3.17M

-39.20%5.32M

-225.19%-2.97M

-83.51%15.53M

-85.32%7.49M

-98.29%215K

Net income continuous Operations

-420.60%-17.04M

29.27%-2.1M

-68.16%4.95M

-107.59%-568K

1,373.02%3.17M

-39.20%5.32M

-225.19%-2.97M

-83.51%15.53M

-85.32%7.49M

-98.29%215K

Minority interest income

Net income attributable to the parent company

-420.60%-17.04M

29.27%-2.1M

-68.16%4.95M

-107.59%-568K

1,373.02%3.17M

-39.20%5.32M

-225.19%-2.97M

-83.51%15.53M

-85.32%7.49M

-98.29%215K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-420.60%-17.04M

29.27%-2.1M

-68.16%4.95M

-107.59%-568K

1,373.02%3.17M

-39.20%5.32M

-225.19%-2.97M

-83.51%15.53M

-85.32%7.49M

-98.29%215K

Basic earnings per share

-425.00%-0.13

0.00%-0.02

-66.67%0.04

-107.23%-0.0043

1,118.03%0.02

-42.86%0.04

-100.00%-0.02

-83.56%0.12

-85.00%0.06

-98.36%0.0016

Diluted earnings per share

-425.00%-0.13

0.00%-0.02

-66.67%0.04

-107.23%-0.0043

1,130.01%0.02

-42.86%0.04

-100.00%-0.02

-82.86%0.12

-84.62%0.06

-98.19%0.0016

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	11.01%130.23M	2.17%109.98M	-3.94%433.14M	-13.73%99.65M	-7.13%108.53M	-3.36%117.32M	10.84%107.64M	-3.52%450.89M	-9.65%115.52M	2.73%116.86M
Operating revenue	11.01%130.23M	2.17%109.98M	-3.94%433.14M	-13.73%99.65M	-7.13%108.53M	-3.36%117.32M	10.84%107.64M	-3.52%450.89M	-9.65%115.52M	2.73%116.86M
Cost of revenue	10.95%29.2M	7.85%28.7M	1.39%106.48M	2.43%27.77M	-1.48%25.79M	-1.26%26.32M	6.09%26.61M	-8.04%105.02M	-16.83%27.11M	0.04%26.18M
Gross profit	11.03%101.04M	0.30%81.28M	-5.56%326.66M	-18.69%71.88M	-8.76%82.74M	-3.96%91M	12.49%81.04M	-2.06%345.87M	-7.20%88.41M	3.53%90.68M
Operating expense	13.38%92.13M	0.11%85.13M	-2.92%314.13M	-8.20%73.15M	-15.98%74.69M	-1.88%81.26M	17.84%85.04M	15.17%323.57M	5.53%79.69M	24.65%88.9M
Selling and administrative expenses	8.85%76.54M	-2.05%72.32M	-4.95%269.75M	-10.12%61.38M	-19.04%64.22M	-3.16%70.32M	16.13%73.83M	13.43%283.81M	1.55%68.29M	27.19%79.33M
Research and development costs	42.50%15.59M	14.35%12.81M	11.61%44.38M	3.29%11.77M	9.35%10.47M	7.18%10.94M	30.45%11.2M	29.34%39.76M	37.95%11.4M	6.95%9.58M
Operating profit	-8.58%8.91M	3.72%-3.85M	-43.84%12.53M	-114.56%-1.27M	352.50%8.05M	-18.35%9.75M	-3,025.78%-4M	-69.12%22.3M	-55.86%8.72M	-89.06%1.78M
Net non-operating interest income expense	-4.38%-620K	20.80%-514K	-9.01%-2.19M	-1,773.33%-502K	22.38%-444K	18.63%-594K	11.94%-649K	72.24%-2.01M	103.52%30K	61.40%-572K
Non-operating interest expense	4.38%620K	-20.80%514K	9.01%2.19M	1,773.33%502K	-22.38%444K	-18.63%594K	-11.94%649K	-72.24%2.01M	-103.52%-30K	-61.40%572K
Other net income (expense)	-81,632.14%-22.83M	0.00%23K	538.46%57K	-516.67%-25K	520.00%31K	233.33%28K	866.67%23K	99.31%-13K	166.67%6K	100.26%5K
Special income (charges)	---22.8M	----	--0	----	----	--0	----	--0	----	----
-Less:Impairment of capital assets	--18.84M	----	----	----	----	--0	----	----	----	----
-Write off	--3.96M	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	-200.00%-28K	0.00%23K	538.46%57K	-516.67%-25K	520.00%31K	233.33%28K	866.67%23K	0.00%-13K	166.67%6K	126.32%5K
Income before tax	-258.41%-14.54M	6.14%-4.34M	-48.76%10.39M	-120.52%-1.8M	530.12%7.64M	-17.93%9.18M	-433.06%-4.63M	-67.85%20.28M	-53.66%8.75M	-90.59%1.21M
Income tax	-35.21%2.5M	-35.28%-2.24M	14.67%5.45M	-196.85%-1.23M	348.35%4.47M	58.32%3.86M	-3,784.44%-1.66M	115.27%4.75M	103.95%1.27M	229.04%997K
Net income	-420.60%-17.04M	29.27%-2.1M	-68.16%4.95M	-107.59%-568K	1,373.02%3.17M	-39.20%5.32M	-225.19%-2.97M	-83.51%15.53M	-85.32%7.49M	-98.29%215K
Net income continuous Operations	-420.60%-17.04M	29.27%-2.1M	-68.16%4.95M	-107.59%-568K	1,373.02%3.17M	-39.20%5.32M	-225.19%-2.97M	-83.51%15.53M	-85.32%7.49M	-98.29%215K
Minority interest income
Net income attributable to the parent company	-420.60%-17.04M	29.27%-2.1M	-68.16%4.95M	-107.59%-568K	1,373.02%3.17M	-39.20%5.32M	-225.19%-2.97M	-83.51%15.53M	-85.32%7.49M	-98.29%215K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-420.60%-17.04M	29.27%-2.1M	-68.16%4.95M	-107.59%-568K	1,373.02%3.17M	-39.20%5.32M	-225.19%-2.97M	-83.51%15.53M	-85.32%7.49M	-98.29%215K
Basic earnings per share	-425.00%-0.13	0.00%-0.02	-66.67%0.04	-107.23%-0.0043	1,118.03%0.02	-42.86%0.04	-100.00%-0.02	-83.56%0.12	-85.00%0.06	-98.36%0.0016
Diluted earnings per share	-425.00%-0.13	0.00%-0.02	-66.67%0.04	-107.23%-0.0043	1,130.01%0.02	-42.86%0.04	-100.00%-0.02	-82.86%0.12	-84.62%0.06	-98.19%0.0016
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data